CXCL8 and asthma: T2-low asthma is characterized by neutrophilic or paucigranulocytic inflammation and the activation of Th1 and/or Th17 cells, ILC1s, ILC3s and the release of specific cytokines (e.g., CXCL8, IL-17) [9, 15].